A GTPase is an enzyme that acts as a molecular switch inside your cells, flipping between “on” and “off” states to control processes like cell growth, movement, and internal transport. It works by binding to a small energy molecule called GTP (guanosine triphosphate) and then breaking it apart. When GTP is bound, the switch is on. When the enzyme chops GTP into GDP (a lower-energy form), the switch flips off. This simple cycle governs an enormous range of cellular functions, and when it goes wrong, it can drive diseases like cancer.
How the On/Off Switch Works
The core idea behind every GTPase is the same: the protein changes shape depending on which molecule is attached to it. In the GTP-bound state, the enzyme takes on an active shape that lets it interact with other proteins and kick off a chain of events inside the cell. Once the enzyme breaks GTP down to GDP by snipping off one phosphate group, it snaps into a different, inactive shape. It stays inactive until the GDP is swapped out for a fresh GTP molecule, resetting the switch.
On its own, a GTPase is sluggish. It can break down GTP, but very slowly. Cells speed this cycle up and keep it tightly controlled using three types of helper proteins:
- GEFs (guanine nucleotide exchange factors) turn the switch on by popping out the spent GDP so a new GTP can slide in.
- GAPs (GTPase-activating proteins) turn the switch off by dramatically accelerating GTP breakdown, sometimes by a factor of thousands.
- GDIs (guanine nucleotide dissociation inhibitors) act as a parking brake. They pull certain GTPases off cell membranes and hold them in an inactive, soluble state in the cell’s interior, preventing the switch from cycling at all until the protein is needed.
This three-part regulatory system gives cells precise control over when and where a GTPase fires. A growth signal arriving at the cell surface, for example, can activate a GEF, which flips on a GTPase, which relays the signal deeper into the cell. A GAP then shuts it down so the signal doesn’t persist longer than it should.
Two Major Categories
GTPases fall into two broad groups based on their size and how they receive signals.
Small GTPases (also called monomeric GTPases) are single proteins roughly 20 to 25 kilodaltons in size. The best known belong to the Ras superfamily, which includes at least six families: Ras, Rho, Rab, Ran, Rheb, and Arf. Each family handles different jobs, covered in detail below.
Heterotrimeric G proteins are larger complexes made of three subunits (alpha, beta, and gamma) that sit on the inner surface of cell membranes. They relay signals from a huge class of receptors called GPCRs, which detect everything from hormones and neurotransmitters to light and odors. When a receptor is activated, the alpha subunit swaps GDP for GTP, separates from the beta-gamma pair, and both pieces go on to trigger downstream effects like changing ion channel activity or altering the production of signaling molecules inside the cell. The alpha subunit’s GTPase core is structurally very similar to the small GTPases, reflecting a shared evolutionary origin.
What Each GTPase Family Does
Ras: Cell Growth and Survival
Ras proteins control whether a cell grows, divides, or differentiates into a specialized type. They sit near the inner surface of the cell membrane and relay signals from growth factor receptors. When Ras gets stuck in the “on” position due to a mutation, cells receive a constant growth signal. Roughly 19% of all cancer patients carry a Ras mutation, making it one of the most commonly mutated gene families in human cancer. That translates to approximately 3.4 million new cases worldwide each year.
Rho: Cell Shape and Movement
The Rho family, including RhoA, Rac1, and Cdc42, controls the cell’s internal skeleton of protein filaments. Each member triggers a distinct structural change. RhoA causes cells to form thick contractile fibers and adhesion points, essentially anchoring the cell and enabling it to pull itself along. Rac1 drives the formation of broad, sheet-like protrusions at the cell’s leading edge. Cdc42 produces thin, finger-like extensions that sense the environment. In a moving cell, Rac1 activity dominates at the front to push forward while RhoA activity concentrates at the rear to retract the tail. This coordinated system is essential for wound healing, immune cell migration, and embryonic development.
Rab: Internal Cargo Transport
With over 60 members in humans, Rab GTPases are the largest family. They act as traffic controllers for the membrane-bound packages (vesicles) that shuttle cargo between compartments inside the cell. Each Rab protein is stationed at a specific location and manages a specific route. Rab1 handles transport from the endoplasmic reticulum to the Golgi apparatus. Rab5 sits on early endosomes and mediates the initial uptake of material from outside the cell. Rab7 governs the maturation of late endosomes and their fusion with lysosomes, the cell’s recycling centers. Rab8 manages traffic from the Golgi to the cell surface, while Rab3 and Rab27 coordinate regulated secretion events where cells release stored cargo on demand. Rab proteins work by recruiting specific partner proteins that physically tether vesicles to the right destination membrane, ensuring packages reach the correct address.
Ran: Nuclear Transport
Ran GTPase controls the flow of molecules between the nucleus and the rest of the cell. A concentration gradient of Ran-GTP (high inside the nucleus, low outside) tells transport machinery which direction to carry cargo through nuclear pores. Ran also plays a critical role during cell division by helping organize the spindle that separates chromosomes.
Arf: Membrane and Lipid Regulation
Arf GTPases help shape the membranes of internal compartments, particularly around the Golgi apparatus. They recruit coat proteins that mold membranes into vesicles and also regulate enzymes involved in lipid metabolism.
GTPases in Protein Synthesis
Beyond signaling and transport, GTPases play a direct role in building new proteins. Two GTPase factors, called elongation factors, are essential for the ribosome (the cell’s protein-making machine) to function accurately and quickly. The first delivers each new amino acid-carrying tRNA to the ribosome, and GTP hydrolysis serves as a checkpoint to verify the correct match between the tRNA and the mRNA code before the amino acid is added to the growing chain. The second elongation factor uses GTP hydrolysis to physically ratchet the ribosome forward by one codon along the mRNA after each amino acid is added, a step called translocation. The tip of this factor mimics the shape of a tRNA molecule, which helps prevent the ribosome from slipping and misreading the genetic code. Every protein your body makes depends on thousands of these GTP-powered steps.
GTPase Mutations and Cancer Treatment
Because Ras GTPases sit at a critical junction in growth signaling, mutations that lock them in the active state are potent cancer drivers. For decades, Ras proteins were considered “undruggable” because their surface is small and smooth, offering few places for a drug molecule to grab hold. That changed in 2021 when the FDA approved the first drug to directly target a mutant Ras protein. This drug, sotorasib, works specifically against a particular mutation called KRAS G12C, found in a subset of non-small cell lung cancers. A second drug, adagrasib, received approval in 2022 for the same mutation.
Both drugs work by locking the mutant protein in its inactive, GDP-bound state, effectively jamming the switch in the “off” position. Several additional drugs targeting KRAS G12C and other Ras mutations are now in advanced clinical trials for lung cancer, colorectal cancer, and pancreatic cancer. The development of these drugs represents a major shift after decades of targeting only the proteins downstream of Ras rather than Ras itself.